Page 132

Revista Medica de Chile Enero 2016

CASOS CLÍNICOS 2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2008. 3. Valbuena JR, Herling M, Admirand JH, Padula A, Jones D, Medeiros LJ. T-cell prolymphocytic leukemia involving 128 extramedullary sites. Am J Clin Pathol 2005; 123 (3): 456-64. 4. Matutes E, García Talavera J, O’Brien M, Catovsky D. The morphological spectrum of T-prolymphocytic leukaemia. Br J Haematol 1986; 64 (1): 111-24. 5. Pérez-Vila MF, Espinet B, Solé F, Pedro C, Woessner S, Florensa L. A new case of Sézary cell leukemia: a morphologic variant of prolymphocytic leukemia, Haematologica 2000; 85 (7): 775-6. 6. Chen X, Cherian S. Immunophenotypic Characterization of T-cell prolymphocytic leukemia. Am J Clin Pathol 2013; 140 (5): 727-35. 7. Odero MD, Matutes E, Valgañón M, Cigudosa JC, Bengoechea E, Calasanz MJ. Complex karyotype in one patient with small cell variant of T-prolymphocytic leukemia. Analysis by G-banding and comparative genomic hybridization. Haematologica 2001; 86 (3): 324-5. 8. Heinonen K, Mahlamaki E, Hamalainen E, Nousiainen T, Mononen I. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic LPL-T variante de células cerebriformes - C. Peña et al leukemia. Cancer Genet Cytogenet 1994; 78 (1): 28-35. 9. Brito-Babapulle V, Catovsky D. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 1991; 55 (1): 1-9. 10. Tirado CA, Starshak P, Delgado P, Rao N. T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role ofcytogenetics: a multidisciplinary approach. Exp Hematol Oncol 2012; 1 (1): 21. 11. Costa D, Queralt R, Aymerich M, Carrió A, Rozman M, Vallespí T, et al. High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia. Cancer Genet Cytogenet 2003; 147 (1): 36-43. 12. Bellanger D, Jacquemin V, Chopin M, Pierron G, Bernard OA, Ghysdael J, et al. Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia. Leukemia 2014; 28 (2): 417-9. 13. Dearden C. How I treat prolymphocytic leukemia. Blood 2012; 120 (3): 538-51. 14. Herling M. Are we improving the outcome for patients with T-cell prolymphocytic leukemia by allogeneic stem cell transplantation? Eur J Haematol 2015; 94 (3): 191-2. Rev Med Chile 2016; 144: 124-128


Revista Medica de Chile Enero 2016
To see the actual publication please follow the link above